Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Occludin antibody (AA 285-430) (FITC)

The Rabbit Polyclonal anti-Occludin antibody has been validated for ELISA. It is suitable to detect Occludin in samples from Human.
Catalog No. ABIN6112515

Quick Overview for Occludin antibody (AA 285-430) (FITC) (ABIN6112515)

Target

See all Occludin (OCLN) Antibodies
Occludin (OCLN)

Reactivity

  • 126
  • 64
  • 44
  • 34
  • 18
  • 12
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
Human

Host

  • 95
  • 39
  • 3
  • 1
Rabbit

Clonality

  • 89
  • 49
Polyclonal

Conjugate

  • 64
  • 11
  • 5
  • 5
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
This Occludin antibody is conjugated to FITC

Application

  • 106
  • 47
  • 36
  • 32
  • 26
  • 26
  • 20
  • 20
  • 17
  • 15
  • 13
  • 6
  • 2
  • 2
  • 1
  • 1
ELISA
  • Binding Specificity

    • 23
    • 16
    • 16
    • 11
    • 9
    • 6
    • 5
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 285-430

    Purification

    Protein G

    Immunogen

    Recombinant Human Occludin protein (285-430AA).

    Isotype

    IgG
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    0.01 M PBS,  pH 7.4, 0.03 % Proclin-300 and 50 % Glycerol.

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C,-80 °C

    Storage Comment

    Aliquot and store at -20 °C or -80 °C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
  • Target

    Occludin (OCLN)

    Alternative Name

    OCLN

    Gene ID

    100506658

    UniProt

    Q16625

    Pathways

    Cell-Cell Junction Organization, Hepatitis C
You are here:
Chat with us!